Bengaluru, India

Krishnamurthy Kulithalai Viswanathan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sami-Sabinsa Group Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishnamurthy Kulithalai Viswanathan. Retrieved from https://idiyas.com/inventor/krishnamurthy-kulithalai-viswanathan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Krishnamurthy Kulithalai Viswanathan

Introduction

Krishnamurthy Kulithalai Viswanathan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of bioconversion, particularly through his innovative work involving curcuminoids.

Latest Patents

Viswanathan holds a patent for the microbial bioconversion of curcuminoids to Calebin-A. This invention discloses a novel endophytic fungus, MTCC 25236, which is utilized for the bioconversion process. The patent also details a method for isolating this fungus from the rhizomes of specific plant species.

Career Highlights

Viswanathan is associated with Sami-Sabinsa Group Limited, where he continues to advance research in bioconversion technologies. His work has the potential to impact various industries, including pharmaceuticals and nutraceuticals.

Collaborations

He has collaborated with notable colleagues such as Muhammed Majeed and Kalyanam Nagabhushanam, contributing to the advancement of innovative solutions in his field.

Conclusion

Krishnamurthy Kulithalai Viswanathan's contributions to the field of bioconversion exemplify the impact of innovative thinking in science and technology. His work continues to inspire advancements in the utilization of natural compounds for health benefits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…